Direct conflict between the US and Iran in the Strait of Hormuz, including attacks on ships and tanker seizures, has pushed crude oil prices over $100/barrel. This energy price shock is a primary driver of economic slowdown in Europe, with Germany halving its GDP growth forecast as a direct consequence.
Tesla announced plans to triple its capital expenditure to over $25 billion, focusing on AI, the Optimus humanoid robot, and autonomous vehicles. This represents a fundamental shift in the company's long-term strategy, moving beyond being just an electric car manufacturer.
A Trump administration policy aimed at aligning US drug prices with lower European prices is causing pharmaceutical firms to delay or withhold new medicines from the European market. Companies are prioritizing access to the more profitable US market, creating uncertainty and potentially limiting European patients' access to new treatments.
Several European nations are facing distinct economic challenges. The Swiss government is imposing stricter capital requirements on UBS, the UK has seen the highest wage tax increase among wealthy nations, and Finland is implementing austerity measures amid high unemployment.
Keep pulling the thread on Drugs Kept From.